TAMPA, Fla. – Startup fundraising strategies, breakthroughs in cancer immunotherapy, and big data mining for patient care improvement will be spotlighted at Moffitt Cancer Center’s 12th annual Business of Biotech Conference: Discovering Tomorrow’s Cancer Cures. The event, which brings together biomedical companies, startups, research organizations, entrepreneurs and investors, offers networking, collaboration and partnership opportunities. This year’s conference is Friday, March 2, 8:30 a.m. – 3 p.m. in Moffitt’s Vincent A. Stabile Research Building.

“The Business of Biotech is an impactful event because it allows for researchers, business professionals, and investors to connect and support one common cause – discovering tomorrow’s cancer cures,” said Jarett Rieger, conference chairman and senior director of Moffitt’s Office of Innovation and Industry Alliances. “It is a day dedicated to learning about and investing into technology that may be able to cure a disease that has taken the lives of so many loved ones.”

This year’s interview-style keynote address features Francis Cuss, MB BChir, FRCP, who is a former Chief Scientific Officer and Vice President of Bristol-Myers Squibb. Prior to his time at Bristol-Myers Squibb, Cuss held high-responsibility positions in the American pharmaceutical company, Schering-Plough, and the European pharmaceutical company, Glaxo. He will be interviewed by Cokie Roberts, ABC News Political Commentator, NPR Contributing Senior News Analyst, and member of the Moffitt Board of Advisors.

“We are honored to have Dr. Cuss as this year’s keynote address speaker,” said Rieger. “With his broad and extensive experience in pharmaceutical research and development, Dr. Cuss has played a leading role in the development of Opdivo (nivolumab), an immunotherapy used to treat certain types of cancer.”

In addition to Cuss’ appearance, the conference will include informative breakout sessions and tours of Moffitt’s hospital and research facilities.

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 5,700 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube